 | Neuropace, Inc. | |||
| NGM : NPCE || Location: United States | ||||
$14.01+0.01 (+0.07%) |
0.15 M | 13.6 - 14.51 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.086 M |
| March 15, 2024 | 0.031 M |
| Feb. 29, 2024 | 0.050 M |
| Feb. 15, 2024 | 0.063 M |
| Jan. 31, 2024 | 0.063 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.32 | -0.23 | 28.42% |
| 09/30/2023 | -0.42 | -0.28 | 33.05% |
| 06/30/2023 | -0.47 | -0.36 | 24.10% |
| 03/31/2023 | -0.47 | -0.41 | 11.85% |
| 12/31/2022 | -0.50 | -0.45 | 10.87% |
NPCE Basic Data
| Sector | Healthcare | Industry | Medical Devices |
| Shares Outstanding | 28.345M | Shares Float | 11.185M |
| Short Float | 0.086M | Market Cap | 397.11M |
| Institution ownership | 79.19% | Insider ownership | 3.948% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.27 | Forward EPS | -1.02 |